| 1 |
27549668 | Effect of Vandetanib on Lung Tumorigenesis in Transgenic Mice Carrying an Activating Egfr Gene Mutation. | 2016 Aug |
5 |
| 2 |
22611027 | Vandetanib, an inhibitor of VEGF receptor-2 and EGF receptor, suppresses tumor development and improves prognosis of liver cancer in mice. | 2012 Jul 15 |
4 |
| 3 |
20629091 | Targeted molecular therapy of head and neck squamous cell carcinoma with the tyrosine kinase inhibitor vandetanib in a mouse model. | 2011 Mar |
2 |
| 4 |
21220477 | Targeted therapy of VEGFR2 and EGFR significantly inhibits growth of anaplastic thyroid cancer in an orthotopic murine model. | 2011 Apr 15 |
1 |
| 5 |
18347145 | Dual inhibition of VEGFR and EGFR signaling reduces the incidence and size of intestinal adenomas in Apc(Min/+) mice. | 2008 Mar |
2 |
| 6 |
18698025 | Vandetanib inhibits growth of adenoid cystic carcinoma in an orthotopic nude mouse model. | 2008 Aug 15 |
3 |
| 7 |
17639056 | A transplantable human medullary thyroid carcinoma as a model for RET tyrosine kinase-driven tumorigenesis. | 2007 Jun |
2 |
| 8 |
17975157 | Investigation of two dosing schedules of vandetanib (ZD6474), an inhibitor of vascular endothelial growth factor receptor and epidermal growth factor receptor signaling, in combination with irinotecan in a human colon cancer xenograft model. | 2007 Nov 1 |
2 |
| 9 |
16052530 | ZD6474 inhibits tumor growth and intraperitoneal dissemination in a highly metastatic orthotopic gastric cancer model. | 2006 Jan 15 |
1 |
| 10 |
16299247 | ZD6474, a novel tyrosine kinase inhibitor of vascular endothelial growth factor receptor and epidermal growth factor receptor, inhibits tumor growth of multiple nervous system tumors. | 2005 Nov 15 |
2 |
| 11 |
14760102 | Antitumor activity of ZD6474, a vascular endothelial growth factor receptor tyrosine kinase inhibitor, in human cancer cells with acquired resistance to antiepidermal growth factor receptor therapy. | 2004 Jan 15 |
1 |
| 12 |
15886878 | The VEGF receptor tyrosine kinase inhibitor, ZD6474, inhibits angiogenesis and affects microvascular architecture within an orthotopically implanted renal cell carcinoma. | 2004 |
1 |
| 13 |
12684431 | Antitumor effects of ZD6474, a small molecule vascular endothelial growth factor receptor tyrosine kinase inhibitor, with additional activity against epidermal growth factor receptor tyrosine kinase. | 2003 Apr |
3 |